Reopening America

Biden’s ‘Test to Treat’ Program Rolled Out This Week, Questions Still Remain

President Biden’s ‘test to treat’ program started rolling out this week to praise and also many questions. People will be able will be able to walk into participating pharmacies or clinics and if they test positive for Covid, they will be given a free course of Pfizer or Merck’s antiviral pills. Questions are still floating around about supply of pills, rapid tests, and concerns over drug to drug interactions. Katie Shepherd, health and science reporter at The Washington Post, joins us for more. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.